Medications for type 2 diabetes and obesity known as GLP-1 receptor agonists may lower the risk of acute pancreatitis recurrence in people with obesity and those with type 2 diabetes, according to a study presented Saturday ...
Jun 1, 2024
0
1
People under age 50 have a greater risk for heart attack or stroke if they've lived with obesity for 10 years, according to industry-sponsored research being presented Saturday at ENDO 2024, the Endocrine Society's annual ...
Jun 1, 2024
0
3
Having medical conditions linked to obesity does not impact the total weight loss achieved with the anti-obesity medication tirzepatide, according to an industry-supported study being presented Saturday at ENDO 2024, the ...
Jun 1, 2024
0
3
Health insurance companies often deny coverage for new medications that treat children and teens with obesity and type 2 diabetes, meaning many patients who need treatment are unable to afford it, according to a study presented ...
Jun 1, 2024
0
1
Specific demographic, clinical, and financial characteristics are associated with glucagon-like peptide 1 (GLP-1) receptor agonist discontinuation, according to a research letter published online May 24 in JAMA Network Open.
May 30, 2024
0
0
Pelvic health is crucial to a woman's overall well-being but is often misunderstood or overlooked. When symptoms such as urinary incontinence, pain or discomfort, or pain during intercourse occur, they are dismissed as a ...
May 29, 2024
0
0
In contemporary society, obesity has emerged as a worldwide chronic metabolic disorder, imposing substantial burdens on both individual health and health care systems. The insulin resistance that accompanies obesity poses ...
May 29, 2024
0
0
The average age at menarche—the first menstrual period—has been decreasing among younger generations in the U.S., especially those belonging to racial minorities and lower socioeconomic statuses, according to a new study ...
May 29, 2024
0
16
Anti-obesity drugs such as Ozempic were the "breakthrough of the year" in 2023, according to the AAAS journal Science. Overweight and obesity rates are rising worldwide, with several Latin American countries in the forefront. ...
May 29, 2024
0
0
The harmful combination of abdominal obesity and reduced muscle strength, also known as sarcopenic obesity, is already present in primary school children. This is shown by a new study among eight-year-olds, conducted at Karolinska ...
May 28, 2024
0
0
